Amid a fierce backlash and likely legal challenges, manufacturer Gilead Sciences asked the FDA yesterday to rescind the deal.
Amid a fierce backlash and likely legal challenges, manufacturer Gilead Sciences asked the FDA yesterday to rescind the deal.